Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Hayes

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2020
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes studySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infectionHamish Innes, Peter Jepsen, Scott McDonald, et al.
Gut|March 29, 2020
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage studySharon J Hutchinson, Heather Valerio, Scott A McDonald, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2019
Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitisEwan H Forrest, Natasha Storey, Rohit Sinha, et al.
The Lancet. Gastroenterology & Hepatology|September 7, 2024
Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumZhujun Cao, Florence Wong, Ashok K Choudhury, et al.
Hepatology (Baltimore, Md.)|February 27, 2015
Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomesHamish A Innes, Scott A McDonald, John F Dillon, et al.
Drug and Alcohol Dependence|June 9, 2016
Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsAmanda Weir, Allan McLeod, Hamish Innes, et al.
Scientific Reports|January 31, 2017
Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liverWesam Gamal, Philipp Treskes, Kay Samuel, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2020
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes studySheila M Grecian, Stela McLachlan, Jonathan A Fallowfield, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infectionHamish Innes, Peter Jepsen, Scott McDonald, et al.
Gut|March 29, 2020
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage studySharon J Hutchinson, Heather Valerio, Scott A McDonald, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2019
Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitisEwan H Forrest, Natasha Storey, Rohit Sinha, et al.
The Lancet. Gastroenterology & Hepatology|September 7, 2024
Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumZhujun Cao, Florence Wong, Ashok K Choudhury, et al.
Hepatology (Baltimore, Md.)|February 27, 2015
Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomesHamish A Innes, Scott A McDonald, John F Dillon, et al.
Drug and Alcohol Dependence|June 9, 2016
Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsAmanda Weir, Allan McLeod, Hamish Innes, et al.
Scientific Reports|January 31, 2017
Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liverWesam Gamal, Philipp Treskes, Kay Samuel, et al.
Pageof 17